Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
1 - 2 μg/mL |
5 μg/mL |
Assay dependent |
Not tested in other applications.
Calculated MW
Positive Control
A549 Cell Slide(GTX25527) , A549 Cell Lysate(GTX27910)
Product Note
This antibody is predicted to have no cross-reactivity to ZBED1 or ZBED3.
Form
Liquid
Buffer
PBS
Preservative
0.02% Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Human
Immunogen
ZBED2 antibody was raised against a 15 amino acid synthetic peptide from near the amino terminus of human ZBED2.The immunogen is located within the first 50 amino acids of ZBED2.
Purification
Purified by antigen-affinity chromatography
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
Synonyms
zinc finger BED-type containing 2
Background
The ZBED2 protein possesses a BED-type zinc finger, a 50 to 60 amino acid domain that contains a characteristic motif with two highly conserved aromatic positions, as well as a shared pattern of cysteines and histidines that is predicted to form the zinc finger. ZBED2 was identified through a screening of 37 human gastric cancer cDNA libraries. While the function of this protein unknown at this time, the presence of the zinc finger suggests that it may have DNA or RNA binding properties. This antibody is predicted to have no cross-reactivity to ZBED1 or ZBED3.
Database